Report Detail

Request for Sample of this report

Other Global Geriatric Medicines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4602289
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Geriatric Medicines market size was valued at USD 733080 million in 2023 and is forecast to a readjusted size of USD 1161440 million by 2030 with a CAGR of 6.8% during review period.
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
The Global Info Research report includes an overview of the development of the Geriatric Medicines industry chain, the market status of Cardiovascular diseases (Analgesics, Antihypertensives), Arthritis (Analgesics, Antihypertensives), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Geriatric Medicines.
Regionally, the report analyzes the Geriatric Medicines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Geriatric Medicines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Geriatric Medicines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Geriatric Medicines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Analgesics, Antihypertensives).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Geriatric Medicines market.
Regional Analysis: The report involves examining the Geriatric Medicines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Geriatric Medicines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Geriatric Medicines:
Company Analysis: Report covers individual Geriatric Medicines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Geriatric Medicines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cardiovascular diseases, Arthritis).
Technology Analysis: Report covers specific technologies relevant to Geriatric Medicines. It assesses the current state, advancements, and potential future developments in Geriatric Medicines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Geriatric Medicines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Geriatric Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Market segment by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
Market segment by players, this report covers
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Geriatric Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Geriatric Medicines, with revenue, gross margin and global market share of Geriatric Medicines from 2019 to 2024.
Chapter 3, the Geriatric Medicines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Geriatric Medicines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Geriatric Medicines.
Chapter 13, to describe Geriatric Medicines research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Geriatric Medicines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Geriatric Medicines by Type
    • 1.3.1 Overview: Global Geriatric Medicines Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Geriatric Medicines Consumption Value Market Share by Type in 2023
    • 1.3.3 Analgesics
    • 1.3.4 Antihypertensives
    • 1.3.5 Statins
    • 1.3.6 Antidiabetics
    • 1.3.7 Proton Pump Inhibitor
    • 1.3.8 Anticoagulant
    • 1.3.9 Antipsychotics
    • 1.3.10 Antidepressants
  • 1.4 Global Geriatric Medicines Market by Application
    • 1.4.1 Overview: Global Geriatric Medicines Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Cardiovascular diseases
    • 1.4.3 Arthritis
    • 1.4.4 Neurological Disorders
    • 1.4.5 Cancer
    • 1.4.6 Osteoporosis
    • 1.4.7 Respiratory
    • 1.4.8 Other
  • 1.5 Global Geriatric Medicines Market Size & Forecast
  • 1.6 Global Geriatric Medicines Market Size and Forecast by Region
    • 1.6.1 Global Geriatric Medicines Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Geriatric Medicines Market Size by Region, (2019-2030)
    • 1.6.3 North America Geriatric Medicines Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Geriatric Medicines Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Geriatric Medicines Market Size and Prospect (2019-2030)
    • 1.6.6 South America Geriatric Medicines Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Geriatric Medicines Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Eli Lilly and Company
    • 2.1.1 Eli Lilly and Company Details
    • 2.1.2 Eli Lilly and Company Major Business
    • 2.1.3 Eli Lilly and Company Geriatric Medicines Product and Solutions
    • 2.1.4 Eli Lilly and Company Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Eli Lilly and Company Recent Developments and Future Plans
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Geriatric Medicines Product and Solutions
    • 2.2.4 AstraZeneca Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AstraZeneca Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Geriatric Medicines Product and Solutions
    • 2.3.4 Boehringer Ingelheim Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.4 Abbott Laboratories
    • 2.4.1 Abbott Laboratories Details
    • 2.4.2 Abbott Laboratories Major Business
    • 2.4.3 Abbott Laboratories Geriatric Medicines Product and Solutions
    • 2.4.4 Abbott Laboratories Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi Geriatric Medicines Product and Solutions
    • 2.5.4 Sanofi Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb
    • 2.6.1 Bristol-Myers Squibb Details
    • 2.6.2 Bristol-Myers Squibb Major Business
    • 2.6.3 Bristol-Myers Squibb Geriatric Medicines Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck Geriatric Medicines Product and Solutions
    • 2.7.4 Merck Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merck Recent Developments and Future Plans
  • 2.8 Novartis
    • 2.8.1 Novartis Details
    • 2.8.2 Novartis Major Business
    • 2.8.3 Novartis Geriatric Medicines Product and Solutions
    • 2.8.4 Novartis Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Novartis Recent Developments and Future Plans
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Geriatric Medicines Product and Solutions
    • 2.9.4 Pfizer Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments and Future Plans
  • 2.10 GSK
    • 2.10.1 GSK Details
    • 2.10.2 GSK Major Business
    • 2.10.3 GSK Geriatric Medicines Product and Solutions
    • 2.10.4 GSK Geriatric Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 GSK Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Geriatric Medicines Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Geriatric Medicines by Company Revenue
    • 3.2.2 Top 3 Geriatric Medicines Players Market Share in 2023
    • 3.2.3 Top 6 Geriatric Medicines Players Market Share in 2023
  • 3.3 Geriatric Medicines Market: Overall Company Footprint Analysis
    • 3.3.1 Geriatric Medicines Market: Region Footprint
    • 3.3.2 Geriatric Medicines Market: Company Product Type Footprint
    • 3.3.3 Geriatric Medicines Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Geriatric Medicines Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Geriatric Medicines Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Geriatric Medicines Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Geriatric Medicines Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Geriatric Medicines Consumption Value by Type (2019-2030)
  • 6.2 North America Geriatric Medicines Consumption Value by Application (2019-2030)
  • 6.3 North America Geriatric Medicines Market Size by Country
    • 6.3.1 North America Geriatric Medicines Consumption Value by Country (2019-2030)
    • 6.3.2 United States Geriatric Medicines Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Geriatric Medicines Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Geriatric Medicines Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Geriatric Medicines Consumption Value by Type (2019-2030)
  • 7.2 Europe Geriatric Medicines Consumption Value by Application (2019-2030)
  • 7.3 Europe Geriatric Medicines Market Size by Country
    • 7.3.1 Europe Geriatric Medicines Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Geriatric Medicines Market Size and Forecast (2019-2030)
    • 7.3.3 France Geriatric Medicines Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Geriatric Medicines Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Geriatric Medicines Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Geriatric Medicines Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Geriatric Medicines Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Geriatric Medicines Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Geriatric Medicines Market Size by Region
    • 8.3.1 Asia-Pacific Geriatric Medicines Consumption Value by Region (2019-2030)
    • 8.3.2 China Geriatric Medicines Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Geriatric Medicines Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Geriatric Medicines Market Size and Forecast (2019-2030)
    • 8.3.5 India Geriatric Medicines Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Geriatric Medicines Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Geriatric Medicines Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Geriatric Medicines Consumption Value by Type (2019-2030)
  • 9.2 South America Geriatric Medicines Consumption Value by Application (2019-2030)
  • 9.3 South America Geriatric Medicines Market Size by Country
    • 9.3.1 South America Geriatric Medicines Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Geriatric Medicines Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Geriatric Medicines Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Geriatric Medicines Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Geriatric Medicines Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Geriatric Medicines Market Size by Country
    • 10.3.1 Middle East & Africa Geriatric Medicines Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Geriatric Medicines Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Geriatric Medicines Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Geriatric Medicines Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Geriatric Medicines Market Drivers
  • 11.2 Geriatric Medicines Market Restraints
  • 11.3 Geriatric Medicines Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Geriatric Medicines Industry Chain
  • 12.2 Geriatric Medicines Upstream Analysis
  • 12.3 Geriatric Medicines Midstream Analysis
  • 12.4 Geriatric Medicines Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Geriatric Medicines. Industry analysis & Market Report on Geriatric Medicines is a syndicated market report, published as Global Geriatric Medicines Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Geriatric Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo